Please wait

Exhibit 107.1

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Treace Medical Concepts, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security 

Type 

 

Security 

Class 

Title 

 

Fee 

Calculation 

Rule 

 

Amount 

Registered(1) 

 

Proposed 

Maximum 

Offering 

Price Per 

Share(2) 

 

Maximum 

Aggregate 

Offering 

Price 

 

Fee 

Rate 

 

Amount of 

Registration 

Fee(4) 

                 
Fees to Be
Paid
  Equity  

Common
Stock, $0.001 

par value per
share

 

457(c)

and 457(h) 

  3,337,692(3)   $20.09   $67,054,232.28   $110.20
per
$1,000,000
  $7,389.38
                 
Fees
Previously
Paid
                 
           
    Total Offering Amounts     $67,054,232.28     $7,389.38
           
    Total Fees Previously Paid         —  
           
    Total Fee Offsets         —  
           
    Net Fee Due               $7,389.38

 

(1)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall also cover any additional shares of the Registrant’s common stock that become issuable under the 2021 Incentive Award Plan (the “2021 Plan”) and the 2021 Employee Stock Purchase Plan (the “ESPP”) by reason of any stock dividend, stock split, recapitalization or similar transaction effected without the Registrant’s receipt of consideration which would increase the number of outstanding shares of common stock.

(2)

This estimate is made pursuant to Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee. The Proposed Maximum Offering Price Per Share for shares available for future grant under the 2021 Plan is the average of the high and low prices for the registrant’s common stock as reported on the Nasdaq Global Select Market on March 7, 2023, which date is within five business days prior to filing this Registration Statement.

(3)

Consists of (i) 2,781,410 additional shares of the Registrant’s common stock that became available for issuance on January 1, 2023 under the 2021 Plan, by operation of an automatic annual increase provision therein and (ii) 556,282 additional shares of the Registrant’s common stock that became available for issuance on January 1, 2023 under the 2021 ESPP, by operation of an automatic annual increase provision therein.

(4)

The Registrant does not have any fee offsets.